How Will Patrys’ $1.77M Entitlement Offer Shape Its Clinical Future?

• Fully underwritten entitlement offer to raise $1.77 million at $0.001 per share
• Three shares offered for every four held plus one free-attaching share per four subscribed
• Secondary offers include options and shares to placement participants and underwriter
• Funds targeted for R&D on PAT-DX3 inflammatory disease therapy and working capital